StemGen, Inc. reported earnings results for the first quarter ended September 30, 2021. For the first quarter, the company reported net loss was USD 0.136027 million compared to USD 0.086674 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1 USD | -.--% | -.--% | -.--% |
2022 | D3eSports Announces Supporting Partnership With United States Esports Federation | CI |
2022 | StemGen, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022 | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 4.57M | |
+3.04% | 61.86B | |
-3.35% | 13.24B | |
+18.54% | 7.71B | |
+6.47% | 6.68B | |
-11.96% | 5.04B | |
+13.19% | 4.37B | |
-20.74% | 4.15B | |
-8.26% | 3.17B | |
+1.53% | 2.97B |
- Stock Market
- Equities
- SGNI Stock
- News StemGen, Inc.
- StemGen, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2021